Investigación > Epidemiología, Enfermedades infecciosas y Salud pública

Farmacología y Microbiología Molecular

Número de publicaciones
226
Buscador de publicaciones

  • Jover-Saenz, A; Santos Rodríguez C; Ramos Gil MÁ; Palomera Fernández M; Invencio da Costa LF; Torres-Puig-gros, J; Castellana Perelló D; Montiu González E; Schoenenberger-Arnaiz, JA; Bordalba Gómez JR; Galindo Ortego X; Ramirez-Hidalgo, M

    Impact of an Antimicrobial Stewardship Strategy on Surgical Hospital Discharge: Improving Antibiotic Prescription in the Transition of Care.

    Antibiotics-Basel 12 -. .

    [doi:10.3390/antibiotics12050834]

  • Stone, P; Buckle, P; Dolan, R; Feliu, J; Hui, D; Laird, BJA; Maltoni, M; Moine, S; Morita, T; Nabal, M; Vickerstaff, V; White, N; Santini, D; Ripamonti, CI

    Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline

    ESMO Open 8 1-13. .

    [doi:10.1016/j.esmoop.2023.101195]

  • Huerva V; Vilardell F; Cid-Bertomeu P

    Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis.

    Case Reports In Ophthalmology 14 111-114. .

    [doi:10.1159/000529667]

  • Rodrigez, JMR; Toda, LI; Lopez, ID; Munoz, JB; Fresno, LS; Hernandez, EF; Munoz, AD

    Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone

    SCIENTIFIC REPORTS 13 -. .

    [doi:10.1038/s41598-023-30281-z]

  • Montellà-Manuel S; Pujol-Carrion N; de la Torre-Ruiz MA

    Aft1 Nuclear Localization and Transcriptional Response to Iron Starvation Rely upon TORC2/Ypk1 Signaling and Sphingolipid Biosynthesis.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .

    [doi:10.3390/ijms24032438]

  • Luis Recuero Díaz J; Almánzar SF; Munoz CG; Sierra JL; Porras ML; Medina DM; Vicuña MN; Moreno LS; Cantalejo MG; Porcel JM

    Recommendations of the Spanish Society of Thoracic Surgery for the management of malignant pleural effusion.

    CIRUGIA ESPANOLA 100 673-683. .

    [doi:10.1016/j.cireng.2022.06.009]

  • Cid-Bertomeu P; Huerva V

    Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.

    SURVEY OF OPHTHALMOLOGY 67 1391-1404. .

    [doi:10.1016/j.survophthal.2022.03.003]

  • Huerva, V; Cid-Bertomeu, P; Espinet, R; Canto, LM

    Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma.

    Ocular Oncology And Pathology 8 88-92. .

    [doi:10.1159/000522195]

  • Vilaltella, M; Vilardell, F; Cid-Bertomeu, P; Huerva, V

    IgG(4)-related orbital disease

    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 57 78-79. .

  • Pujol-Carrion N; Gonzalez-Alfonso A; Puig S; de la Torre-Ruiz MA

    Both human and soya bean ferritins highly improve the accumulation of bioavailable iron and contribute to extend the chronological life in budding yeast.

    Microbial Biotechnology 15 1525-1541. .

    [doi:10.1111/1751-7915.13939]

  • López-Siguero JP; Martínez-Aedo MJ; Bermúdez de la Vega JA; Bosch-Muñoz J; Lechuga-Sancho AM; Villalobos T

    Growth hormone treatment does not to lead to insulin resistance nor excessive rise in IGF-1 levels, while improving height in patients small for gestational age A long-term observational study.

    CLINICAL ENDOCRINOLOGY 96 558-568. .

    [doi:10.1111/cen.14626]

  • Vilaltella, M; Huerva, V

    The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size

    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA 85 109-114. .

    [doi:10.5935/0004-2749.20220018]